Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

126.50p
   
  • Change Today:
      0.50p
  • 52 Week High: 139.50p
  • 52 Week Low: 96.00p
  • Currency: UK Pounds
  • Shares Issued: 104.77m
  • Volume: 46,528
  • Market Cap: £132.54m
  • RiskGrade: 98

Cello Health Overview

Cello Health is in the health care sector and is currently trading at 126.50p per share. In the last year Cello Health's share price has ranged from 96.00p to 139.50p and brokers are currently rating this stock as 'strong buy'.

Key Personnel

CEO: Mark Scott
Executive Director: Julia Ralston
Group COO: Stephen Highley
Group Finance Director: Mark Bentley
Independent Non-Executive Director: Jo LeCouilliard
Independent Non-Executive Director: Clifford Tompsett
Non-Executive Chairman: Christopher Jones
Non-Executive Dir: Michele Luzi

Contact Details

Address: Queens House, 8-9 Queen Street, London, United Kingdom, EC4N 1SP
Phone: +44 (0)20 7812 8460
Fax: +44 (0)20 7253 5376

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share
ISIN: GB00B0310763

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 126.50p
Change Today 0.50p
% Change 0.40 %
52 Week High 139.50p
52 Week Low 96.00p
Volume 46,528
Shares Issued 104.77m
Market Cap £132.54m
RiskGrade 98

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
67.74% below the market average67.74% below the market average67.74% below the market average67.74% below the market average67.74% below the market average
48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average
Price Trend
9.00% above the market average9.00% above the market average9.00% above the market average9.00% above the market average9.00% above the market average
15.00% above the sector average15.00% above the sector average15.00% above the sector average15.00% above the sector average15.00% above the sector average
Income
9.98% above the market average9.98% above the market average9.98% above the market average9.98% above the market average9.98% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
32.51% below the market average32.51% below the market average32.51% below the market average32.51% below the market average32.51% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Oct-19 25-Apr-19
Paid 01-Nov-19 24-May-19
Amount 1.15p 2.75p

Trades for 19-Sep-2019

Time Volume / Share Price
16:31 17,365 @ 127.09p
15:03 3,930 @ 127.00p
13:45 3,905 @ 126.25p
12:50 4,000 @ 127.07p
12:47 2,500 @ 127.07p

Cello Health Key Personnel

CEO Mark Scott

Top of Page